BioCardia CEO Altman Peter Buys 700 Shares at $1.83/Share on 2023-08-22.

BioCardia, Inc. (BCDA) has recently announced that Director, President, and CEO Peter Altman has purchased 700 shares at a price of $1.83 per share on August 22, 2025.

BioCardia, Inc. (BCDA) has recently announced that its Director, President, and CEO, Peter Altman, has purchased 700 shares of the company's common stock. The transaction took place on August 22, 2025, at a price of $1.83 per share. This purchase was reported to the U.S. Securities and Exchange Commission (SEC) through a Form 4 filing [1].

The filing details the transaction, noting that the shares were acquired directly, with the total purchase amounting to $1,284.40. The transaction was executed in multiple trades, with prices ranging from $1.82 to $1.89 per share. The reported price reflects the weighted average per share sales price.

This insider trading activity, as reported, is significant for investors as it provides insights into the company's leadership's confidence in its current financial position and future prospects. The purchase of shares by a high-ranking executive like Altman can often be seen as a positive indicator, suggesting that the executive believes in the company's long-term growth potential.

Investors should closely monitor future developments and earnings reports from BioCardia, Inc. to assess the impact of this transaction on the company's financial performance and stock price.

References:
[1] https://www.stocktitan.net/sec-filings/BCDAW/form-4-bio-cardia-inc-warrant-insider-trading-activity-7e3cd17c8a32.html